Nightingale Health quarterly summary of achieved key milestones and reiteration of near-term business targets
Company Release1 July 2021 at 9:25 a.m. (Finnish time)After the commencement of trading ofin its series B shares on Nasdaq First North Growth Market in March 2021, Nightingale Health Oyj (“Nightingale”) has completed the following milestones during the quarter started in April 2021 and ended in June 2021: · In April 2021, Nightingale’s fully owned subsidiary received clinical laboratory certification in Japan. Receiving the clinical laboratory certification prepared Nightingale for commercial launch of its service in Japan. · In April 2021, Nightingale entered into a strategic